Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Cancer Res. 2009 May 12;69(10):4116–4124. doi: 10.1158/0008-5472.CAN-08-3441

Figure 3.

Figure 3

Expression of claudin-low and stem cell markers in breast cancer subgroups. Using data from transcriptional profiling, metaplastic (Metap) and claudin-low tumors express low levels of claudins CLDN3, CLDN4, and CLDN7 of CDH1 (E-cadherin) and high CD44/CD24 and CD29/CD24 ratios. P values (ANOVA). P values for the metaplastic-basal comparison of stem cell markers were 0.41 (BMI1), 0.19 (CD44), 0.004 (CD29), 0.00009 (CD24), 0.00006 (CD44/CD24 ratio), and 0.00007 (CD29/CD24 ratio).